Aryl-Hydrocarbon Hydroxylase
Among first degree relatives of lung cancer patients who smoke, their risk of developing lung cancer is 14 times greater than a non-smoker without a family history of lung cancer. Attempts have been made to correlate this genetic susceptibility with an increased inducibility of the enzyme aryl-hydrocarbon hydroxylase (AHH). However, results have been inconsistent.